NCT05917652 (ACTUATE) is a clinical trial of Tool kit in Telemedicine, sponsored by University of Pennsylvania.

Who is sponsoring NCT05917652?

NCT05917652 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT05917652?

Interventions in NCT05917652: Tool kit.

What condition does NCT05917652 study?

NCT05917652 studies Telemedicine.

Is NCT05917652 still recruiting?

NCT05917652 is currently recruiting now. Last updated 30 July 2025.

Last reviewed 2025-07-30 · How we verify

NCT05917652: ACTUATE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Actuate-CBC Study

Recruiting now Last updated 30 July 2025

What this trial tests

trial testing Tool kit in Telemedicine in 2,183 participants. Currently enrolling.

Timeline

4 January 2023

Primary endpoint
30 June 2026

15 June 2027

Quick facts

Lead sponsor	University of Pennsylvania
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,183
Start date	4 January 2023
Primary completion	30 June 2026
Estimated completion	15 June 2027
Sites	4 locations across United States

Drugs / interventions tested

Tool kit

Conditions studied

Telemedicine — all drugs for Telemedicine →

Sponsor

University of Pennsylvania

Who can join

18 and older, any sex, with Telemedicine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study team will use implementation science to accelerate the uptake of teleconsultationfor burn patients by 1) examining the relationships between clinician perceptions of acceptability, feasibility, intention to use, and actual use of burn teleconsultation 2) identifying the optimal process for burn teleconsultation and the barriers and facilitators for its use during a crisis or prolonged care situation, and 3) designing and testing the effectiveness of a specific, tailored burn teleconsultation toolkit intervention to increase burn teleconsultation use.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Telemedicine

Currently open trials in the same condition.

NCT07265037 — Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management · NA · recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07124325 — Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care · NA · recruiting
NCT06942533 — Effect of Visual Feedback From the SpiroGym Mobile Application · NA · recruiting
NCT06980740 — Video-Tumorboard PLUS · recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05917652 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 30 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05917652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing